THE KPM GROUP DC LLC

Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $20,000.00 income · posted Apr 20, 2026

Bills named in this filing 5

HR 7118
Genomic Answers for Children’s Health Act of 2026
HR 1414
Cameron’s Law
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S 832
EPIC Act of 2025
S 3019
No Big Blockbuster Bailouts Act

Lobbying activity 1

Health Issues

H.R.7118, Genomic Answers for Childrens Health Act H.R.1414, Camerons Law H.R.1492/S.832, EPIC Act S.3019, No Big Blockbuster Bailouts Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.